← FDA DRUG APPROVALS

FDA NDA · NDA060014

PERMAPEN

Sponsor: CASPER PHARMA LLC

APPLICATION
NDA060014
TYPE
NDA
ORIGINAL APPROVAL
1952-12-16
LATEST ACTION
2000-02-18
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PERMAPENDiscontinued
PENICILLIN G BENZATHINE 600,000 UNITS/ML · INJECTABLE · INJECTION

Approval history

2000-02-18Labeling · Supplement 2AP
1989-08-08Manufacturing (CMC) · Supplement 1AP
1952-12-16OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →